BR112016014512A2 - formulações farmacêuticas líquidas de pemetrexede - Google Patents
formulações farmacêuticas líquidas de pemetrexedeInfo
- Publication number
- BR112016014512A2 BR112016014512A2 BR112016014512-7A BR112016014512A BR112016014512A2 BR 112016014512 A2 BR112016014512 A2 BR 112016014512A2 BR 112016014512 A BR112016014512 A BR 112016014512A BR 112016014512 A2 BR112016014512 A2 BR 112016014512A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical formulations
- liquid pharmaceutical
- pemetrexed
- pemetrexed liquid
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN5951/CHE/2013 | 2013-12-19 | ||
| IN5951CH2013 | 2013-12-19 | ||
| PCT/IB2014/067123 WO2015092758A1 (en) | 2013-12-19 | 2014-12-19 | Liquid pharmaceutical formulations of pemetrexed |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016014512A2 true BR112016014512A2 (pt) | 2018-05-22 |
Family
ID=53402208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016014512-7A BR112016014512A2 (pt) | 2013-12-19 | 2014-12-19 | formulações farmacêuticas líquidas de pemetrexede |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20170128575A1 (pt) |
| BR (1) | BR112016014512A2 (pt) |
| WO (1) | WO2015092758A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4011377A1 (en) | 2015-02-13 | 2022-06-15 | Sun Pharmaceutical Industries Ltd | Intravenous infusion dosage form |
| US20170239250A1 (en) | 2016-02-19 | 2017-08-24 | Eagle Pharmaceuticals, Inc. | Pemetrexed formulations |
| WO2018002956A1 (en) * | 2016-06-27 | 2018-01-04 | Sun Pharmaceutical Industries Ltd. | Stable injectable solution of pemetrexed |
| FR3057775B1 (fr) | 2016-10-26 | 2018-11-02 | Crossject | Solution pharmaceutique d’hydrocortisone pour dispositif d’injection |
| WO2018127743A1 (en) * | 2017-01-05 | 2018-07-12 | Orbicular Pharmaceutical Technologies Private Limited | Ready to infuse pemetrexed liquid compositions |
| CA3137265A1 (en) * | 2019-05-01 | 2020-11-05 | Intas Pharmaceuticals Ltd. | A stable, ready to use aqueous pharmaceutical composition of pemetrexed |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010030598A2 (en) * | 2008-09-11 | 2010-03-18 | Dr. Reddy's Laboratories Limited | Pharmaceutical formulations comprising pemetrexed |
| KR101069128B1 (ko) * | 2011-03-10 | 2011-09-30 | 건일제약 주식회사 | 페메트렉시드 또는 그의 염을 포함하는 항산화제-비함유 주사용 용액 형태의 약학적 제제의 제조방법 |
-
2014
- 2014-12-19 US US15/106,311 patent/US20170128575A1/en not_active Abandoned
- 2014-12-19 WO PCT/IB2014/067123 patent/WO2015092758A1/en active Application Filing
- 2014-12-19 BR BR112016014512-7A patent/BR112016014512A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20170128575A1 (en) | 2017-05-11 |
| WO2015092758A1 (en) | 2015-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR21C1059I2 (fr) | Compositions pharmaceutiques | |
| DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
| DK3479819T3 (da) | Stabilt væskeformigt farmaceutisk præparat | |
| BR112014028602A2 (pt) | formulação líquida. | |
| BR112016026879A2 (pt) | Composição farmacêutica líquida | |
| DK3382201T3 (da) | Flydende legeme-struktur | |
| CL2016001313A1 (es) | Formulaciones listas de fertilizante líquido de bifentrina. | |
| CL2014000864S1 (es) | Envase de medicamento | |
| CL2014000866S1 (es) | Envase de medicamento | |
| DK3145488T3 (da) | Flydende farmaceutiske forbindelse | |
| CL2014003283A1 (es) | Formulación farmacéutica. | |
| BR112016014512A2 (pt) | formulações farmacêuticas líquidas de pemetrexede | |
| DK2854765T3 (da) | Farmaceutisk pemetrexed-opløsning | |
| ES2651188T8 (es) | Composición líquida fotopolimerizable | |
| SG11201509194SA (en) | Radiomitigating pharmaceutical formulations | |
| DK2735305T3 (da) | Stabiliserede flydende farmaceutiske præparater | |
| UA30071S (uk) | Флакон для косметичних засобів | |
| DK3079667T3 (da) | Farmaceutiske doseringsformer | |
| DK3003401T3 (da) | Farmaceutisk præparat | |
| FR3004907B1 (fr) | Cosmetique liquide | |
| DK2983747T3 (da) | Lægemiddelindgivelsesindretning | |
| HUP1300496A2 (hu) | Stabil kombinációs gyógyszerkészítmény | |
| DK3060213T3 (da) | Farmaceutiske sammensætninger omfattende antibakterielle midler | |
| DK2975989T3 (da) | Dispenseranordning | |
| BR112014021433A2 (pt) | formulações farmacêuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2473 DE 29-05-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |